Sir: The latissimus dorsi flap is a reliable method of reconstructing any part of the body.1 Breast reconstruction using the latissimus dorsi flap is popular because it is reliable, not technically demanding, and cosmetically acceptable.2 Despite its popularity, it is associated with a complication rate of approximately 25 percent.3 The most common complication is the development of donor-site seroma that occurs in 21 to 79 percent of cases.4 Several different techniques have been documented in the management of seroma with variable results, including pressure dressings, repeated aspirations, long-term drains, talc poudrage, benign neglect, fibrin sealant, quilting sutures, and triamcinolone injections.1,4 Occasionally, seromas can become refractory to different treatments. In this article, we describe a patient with chronic donor-site seroma managed successfully by simple modification of the foam used in topical negative pressure dressings [vacuum-assisted closure (V.A.C.; Kinetic Concepts, Inc., San Antonio, Texas)]. A 65-year-old woman was referred with a chronic donor-site seroma and clinically symptomatic infection 3 years following primary breast reconstruction using a latissimus dorsi flap with axillary node clearance for breast carcinoma. During these 3 years, she had recurrent seromas that required aspirations. These became infected and resulted in recurrent episodes of donor-site infection. On examination, she was found to have a seroma that was treated initially with ultrasound-guided drainage and steroid injection. This recurred quickly and required further aspiration. Because of its refractory nature, the decision was made to treat the seroma and its capsule surgically by excision and application of vacuum-assisted closure. Intraoperatively, she was found to have a large capsule, which was excised completely (Fig. 1, left). The wound was left open as an ellipse. A microporous polyvinyl alcohol foam (V.A.C. Vers-Foam) was used in the cavity because of its high tensile strength. Four digitations were created in the foam as in Figure 1, right. These were then branched into the different corners of the cavity and the vacuum-assisted closure dressing was applied (Fig. 2, left). This process helped to promote granulation from all directions of the cavity and eliminate the possibility of forming loculations inside the cavity. The patient had dressing changes every 5 days. Before dressing changes, 30 ml of 0.25% bupivacaine was injected into the cavity through the vacuum-assisted closure tubing and left for 30 minutes to anesthetize the sensitive granulation tissue when the sponge was removed. Similar digitations with shorter limb length were created in the subsequent dressing changes. The wound healed well and she has remained without recurrence of seroma for 1 year (Fig. 2, right).Fig. 1.: (Left) The seroma capsule completely excised. (Right) The digitations created on the foam.Fig. 2.: (Left) The vacuum-assisted closure dressing in place with the normal vacuum-assisted closure foam on top of the polyvinyl alcohol foam inside the cavity. (Right) The completely healed wound.Donor-site seroma is the commonest complication following latissimus dorsi breast reconstruction. Although small seromas resolve spontaneously, a collection greater than 100 ml is associated with complications such as wound dehiscence, implant exposure, and infection, and is best treated by drainage.5 Occasionally, seromas are refractory, requiring further treatment in the form of steroid injections. In our case, the patient had a refractory seroma that was treated successfully by designing the foam to digitate into all corners of the cavity and applying topical negative-pressure dressing. Jagajeevan Jagadeesan, M.R.C.S. Marcus Bisson, F.R.C.S.(Plast.) Anthony Graeme Bowman Perks, F.R.C.S., F.R.C.S.(Plast.), F.R.A.C.S.(Plast.) Department of Plastic and Reconstructive Surgery; Nottingham City Hospital; Nottingham, United Kingdom